Johnson & Johnson (JNJ) Other financing activities (2012 - 2026)

Johnson & Johnson has disclosed Other financing activities across 13 years of filings, most recently posting -$588.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$588.0 million, down 1570.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$662.0 million (down 627.47% YoY), and the FY2025 annual result was -$34.0 million, up 10.53% from the prior year.
• Other financing activities came in at -$588.0 million for Q1 2026 at Johnson & Johnson, down from -$26.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $186.0 million in Q3 2023 to a low of -$588.0 million in Q1 2026.
• The 5-year median for Other financing activities is -$37.5 million (2025), against an average of -$76.8 million.
• Across the five-year window, Other financing activities slumped 4700.0% in 2023 and jumped 138.91% in 2024, its largest moves.
• Johnson & Johnson's Other financing activities stood at -$138.0 million in 2022, then tumbled by 178.26% to -$384.0 million in 2023, then surged by 80.47% to -$75.0 million in 2024, then surged by 65.33% to -$26.0 million in 2025, then slumped by 2161.54% to -$588.0 million in 2026.
• The last three Other financing activities figures came in at -$588.0 million (Q1 2026), -$26.0 million (Q4 2025), and -$49.0 million (Q3 2025), per Business Quant data.